Interferon-α adjuvant therapy decreases the recurrence of early clear cell renal cell carcinoma and improves the prognosis of Chinese patients.

about

Interferon-α adjuvant therapy decreases the recurrence of early clear cell renal cell carcinoma and improves the prognosis of Chinese patients.

Item

http://www.wikidata.org/entity/Q49184688

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Interferon-α adjuvant therapy ...... prognosis of Chinese patients.

@en

Interferon-α adjuvant therapy ...... prognosis of Chinese patients.

@nl

type

Item

label

Interferon-α adjuvant therapy ...... prognosis of Chinese patients.

@en

Interferon-α adjuvant therapy ...... prognosis of Chinese patients.

@nl

prefLabel

Interferon-α adjuvant therapy ...... prognosis of Chinese patients.

@en

Interferon-α adjuvant therapy ...... prognosis of Chinese patients.

@nl

P1476

Interferon-α adjuvant therapy ...... prognosis of Chinese patients.

@en

P2093

Cheng-Gong Liao

http://www.w3.org/2001/XMLSchema#string

Hang Yin

http://www.w3.org/2001/XMLSchema#string

Jian-Guo Huang

http://www.w3.org/2001/XMLSchema#string

Lu-Lu Fan

http://www.w3.org/2001/XMLSchema#string

Men-Long Qian

http://www.w3.org/2001/XMLSchema#string

Nao Wan

http://www.w3.org/2001/XMLSchema#string

Ning Lu

http://www.w3.org/2001/XMLSchema#string

Yong-Qiang Wang

http://www.w3.org/2001/XMLSchema#string

Zheng Li

http://www.w3.org/2001/XMLSchema#string

P2860

Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines.

Dimethoxycurcumin, a structural analogue of curcumin, induces apoptosis in human renal carcinoma caki cells through the production of reactive oxygen species, the release of cytochrome C, and the activation of caspase-3.

Gene expression profile of peripheral blood lymphocytes from renal cell carcinoma patients treated with IL-2, interferon-α and dendritic cell vaccine.

Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines

EAU guidelines on renal cell carcinoma: 2014 update.

Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-α2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo.

Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4⁺ and CD8⁺ T cells.

Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer.

Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria.

Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis.

P304

113185-113193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18567

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29348897

http://www.w3.org/2001/XMLSchema#string

P932

5762582

http://www.w3.org/2001/XMLSchema#string